Webb23 sep. 2024 · Therap Adv Gastroenterol. 2024; ... Fusarium and Trichoderma genera, respectively, were significantly enriched in adjacent biopsy samples in advanced adenoma compared with samples of nonadvanced adenoma which may be useful for early diagnosis. 6 In a mycobiome study of 29 polyps, ... WebbTherapeutic Advances in Gastroenterology-期刊论坛,投稿经验-MedSci.cn THER ADV GASTROENTER 润色咨询 Therapeutic Advances in Gastroenterology 出版年份:暂无数据 年文章数:78 投稿命中率:62.5% 出版周期:Bimonthly 自引率:1.3% 审稿周期:平均2.33月 前往期刊查询 期刊讨论 中国SCI论文 期刊主页 投稿经验 杂志官网 投稿链 …
Management of regorafenib-related toxicities: a review - PubMed
WebbPersistent and Enhanced Elimination of Bacteria-Induced Periodontitis Using a Local Drug Delivery Nanoreactor Adv. Therap. (IF 5.003) Pub Date : 2024-10-22. Lihua Xu, Shileng Chen, Yushuo Feng, Ming Chen, Yaqing Liu, Xiaoqian Ma, Jinpeng Jing, Shanshan Meng, Youliang Yao, Wenjing Sun, Hongmin Chen. 更新日期:2024-10-22. Webb15 sep. 2024 · Advanced Search. Search Menu. Despite diagnostic and therapeutic improvements, the limitations in defining and achieving treatment targets for Crohn’s disease [CD] still exist. ... Therap Adv Gastroenterol. 2024; 11: 1756284818771367. Google Scholar. Crossref. Search ADS. PubMed signed for second class
therap adv gastroenterol 是什么杂志
WebbEvolving paradigms in the treatment of opioid-induced bowel dysfunction. Therap Adv Gastroenterol. 2015 Nov;8(6):360- 72. doi: 10.1177/1756283X15589526. Review. PubMed PMID: 26557892; PubMed Central PMCID: PMC4622283. Methylnaltrexone does not pass the blood-brain-barrier due to its ammonium group. Webb10 dec. 2024 · Year 2024. PubMed DOI Crossref. Real-world effectiveness of vedolizumab in inflammatory bowel disease: week 52 results from the Swedish prospective … Webb7 feb. 2024 · Therap Adv Gastroenterol. 2024; 13: 1756284820902878. Published online 2024 Feb 7. doi: 10.1177/1756284820902878. PMCID: PMC7011337. PMID: 32095161. Efficacy, safety, and tolerability of a ready-to-drink bowel preparation: subanalysis by age from a phase III, assessor-blinded study. the prothom-alo